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Introduction: This study examined the patterns and the prevalence of 
obstructive lung disease (asthma and COPD) and associated risk factors 
(age, gender, atopy, smoking history, allergic history, previous history of lung 
disease, occupational exposures, seafood intake) in a working population of 
seafood processing workers along the West coast of the Western Cape of 
South Africa. Materials and method: A cross-sectional study was conducted 
on 643 currently employed workers in two fish processing plants working in 
fish canning and fishmeal processing. A modified version of the European 
Community Respiratory Health Survey (ECRHS) questionnaire was used. 
Skin prick tests (SPT) used extracts of common airborne allergen. Lung 
function spirometry and methacholine challenge tests (tidal breathing method) 
were conducted using Vitallograph S-model bellows volume-time spirometers 
according to ATS guidelines. Serum omega-3 and omega-6 fatty acid levels 
were also analysed to examine the association between dietary fatty acids 
and asthma outcomes. Multivariate regression models were developed for 
asthma outcomes after adjusting for age, gender, sex and atopic status whilst 
the models were adjusted for age, gender and smoking history for COPD 
outcomes. Results: The overall prevalence of asthma symptoms (asthma 
attack I dyspnoea causing sleep disturbancel tight chest causing sleep 
disturbance in the past 12 months) was 11 %. The prevalence of non-specific 
bronchial hyperresponsiveness (PC 20 < 8 mg/rnl or >12% increase in FEV1 
post bronchodilator) was 26% whilst the prevalence of current asthma 











bronchial hyperresponsiveness was 6%. Atopy (defined as a positive SPT one 
or more common aeroallergens) was present in 37% of the population. The 
prevalence of COPO symptoms (reporting a chronic productive cough for 3 
months in 2 consecutive years) was 3% whilst those with obstructive 
impairment on spirometry (FEV1/FVC <70%) comprised 5% of the population. 
Overall 3% had evidence of both obstructive impairment and a post-
bronchodilator FEV1<80% predicted which provided a better rel1ection of the 
true prevalence of COPO. Multivariate logistic regreSSion revealed that a 
history of chronic bronchitis (OR range, 2.45 - 23.82), chest infections in 
childhood (OR range, 3.04 - 21.08) and the presence of work-related wheeze 
or tight chest (OR range, 2.01 - 6.80) were significantly associated with all 
asthma outcomes. Experiencing peak exposures to vapours and dust at work 
were associated with current asthma (OR, 3.70; 95% CI, 1.72 - 7.93) and 
doctor-diagnosed asthma (OR, 2.56; 95% CI, 1.31 - 5.02). In the bivariate 
analysis, atopy on its own, or specific sensitisation to HOM or one of the 
indoor allergens (cat, dog, cockroach, house dust mite) was also significantly 
associated with all asthma outcomes. Omega- 6 (n-6) series fatty acid levels 
of Linolenic acid (18:2), Oihomo gamma linoleic acid (20:3) 
(OR, 1.84; 95%CI, 1.38 - 2.47) and total n-6 (OR, 1.14; 95%CI, 1.08 - 1.21) 
were positively associated with NSBH in multivariate regression models. In 
the omega-3 series, Eicosapentoic acid (20:5) (OR, 0.66; 95%CI, 0.54 - 0.80) 
and docosapentaenoic acid (22:5) (OR, 0.37; 95% CI, 0.20 - 0.69) were found 
to be negatively associated with NSBH. Consistent predictors of COPO 
outcomes were a history of previous TB treatment (OR range, 2.98 - 4.47). 















range, 5.53 -19.65), whilst occupational characteristics (OR range, 4.22-
11.34) were associated with symptoms of chronic bronchitis only. 
Conclusion: This study demonstrated a strong link between pre-existing 
respiratory diseases, such as pulmonary TB and childhood chest infections, 
and obstructive lung disease manifesting as either asthma or COPD. 
Workplace exposures, in particular peak exposures to dust and vapours, as 
well as sensitization to indoor inhalant allergens are added risk factors, while 
high serum levels of omega-3 polyunsaturated fatty acids (derived from 
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW 
1.1 INTRODUCTION 
Obstructive lung disease manifests predominantly as either asthma or chronic 
obstructive pulmonary disease (COPD). Asthma is considered a chronic 
inflammatory disorder of the airways that causes recurrent episodes of 
coughing, wheezing, chest tightness and dyspnoea with limitation of airflow 
which is usually reversible. Inflammation makes the airways sensitive to 
stimuli such as allergens, chemical irritants, tobacco smoke, cold air or 
exercise. 1 It has recently been recognized that asthma is probably not a 
single disease but represents multiple, separate syndromes that overlap. In 
adult asthma different phenotypes exist which may be classified on the basis 
of clinical or physiological characteristics, trigger factors or inflammatory 
phenotype and there may be considerable overlap between these phenotypes 
(see figure 1).2 
COPD is a chronic disease characterized by airflow limitation which is 
progressive, not fully reversible and is associated with an abnormal 
inflammatory response of the lungs to noxious particles or gases.1 Whilst 
efforts have been made to standardize the diagnosis of COPD with the 
development of the Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) guidelines, the reliance on spirometry means that very few 
developing countries are able to implement these guidelines.3 It is generally 
agreed though that COPD is under-diagnosed in developing countries and is 
likely to rise dramatically over the next two decades in tandem with an 














Early/childhood onset phenotypes 
Late/adult onset 
Figure 1 Diagram depicting different and overlapping asthma phenotypes in adults and 
children 
Source: Wenzel SE. Asthma: defining of the persistent adult phenotypes. The Lancet August 











Despite the public health burden imposed by obstructive lung disease few 
studies in developing countries have focussed on the prevalence or incidence 
of this disease and the risk factors contributing to such a disease in the 
general population.5,6,7 Epidemiological studies of obstructive lung disease 
and associated risk factors have also been vulnerable to bias due to the lack 
of standardized definitions for COPD and asthma, a reliance on self-reported 
symptoms defining outcomes and the multifactorial nature of these diseases.1 
There is a need therefore to use validated and explicit definitions when 
measuring the prevalence of obstructive lung disease that is supported by 
objective measures such as spirometry and tests of airway 
hyperresponsiveness. The use of tests of non-specific bronchial 
hyperresponsiveness (NSBH) and spirometry to support and lend credence to 
prevalence estimates has been limited due to cost and a lack of expertise 
particularly in developing countries. 
3  
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1.2 LITERATURE REVIEW 
1.2.1 PREVALENCE AND DETERMINANTS OF ASTHMA 
It is estimated that globally 300 million people of all ages and ethnic 
backgrounds currently have asthma and that asthma accounts for 1 in every 
250 deaths worldwide.s In sub-Saharan Africa asthma prevalence appears to 
be growing and the increase in part is related to the rapid rate of urbanization. 
Asthma appears to be uncommon in rural areas and it is postulated that 
asthma and allergy may be associated with the adoption of an urbanized 
"western" Iifestyle.9 Limited research has been done on the determinants of 
asthma in adult populations of the developing world although large multi-
centric studies such as the International study on asthma and allergy in 
childhood (ISAAC) study have focussed on asthma among the children of 
developing countries. A population-based Turkish study focussing on asthma 
prevalence (yes to having been treated for asthma in the past year and/or 
ever having an asthma attack) in adults (N=1000) found the prevalence of 
asthma, allergic rhinitis and atopy to be 9.4%,27.7% and 31.1% 
respectively. 10 A recent large and nationally representative survey of adults 
(20-44 years) in South Africa revealed the prevalence of asthma diagnosis 
(ever having been diagnosed with asthma by a doctor or a nurse) to be 2.7% 
in men and 3.1 % in women whilst the prevalence of recent wheeze was 
reported by 11.7% of men and 14.5% of women, suggesting that asthma is a 
significant public health problem in SA. As with COPO, occupational 
exposures and a past history of TB were consistent predictors of both 













(PAF) of occupational exposure was 12.2% for recent wheeze and 13.6% for 
asthma diagnosis whilst the PAF for TB was 5.4% for recent wheeze and 
2.7% for asthma diagnosis. However, a limitation of the study was a reliance 
on self-reported symptoms to define asthma outcomes resulting in an inability 
to distinguish between subjects with COPO and asthma. 
Bronchial hyperresponsiveness to non-specific stimuli such as cold air and 
exercise is one of the cardinal features of asthma. 11 A recent South African 
study investigating risk factors for non-specific bronchial hyperresponsiveness 
(NSBH) in persons aged 1544 found that self-reported wheezing, a diagnosis 
of asthma, use of asthma medication and nasal allergy were significantly 
associated with NSBH. Other significant cofactors that displayed positive 
associations with NSBH were female sex [Odds ratio (OR), 3.6; 95% 
Confidence Interval (CI), 1.8-7], ever having worked in a job causing 
wheezing/chest tightness (OR, 6; 95% CI, 2.5-14.5) and a positive skin prick 
test (Spn for Aspergillus mould (OR, 2.5; 95% CI, 1-6) and Timothy grass 
pollen (OR, 2.2; 95% CI, 1.14.5).12 
1.2.2 PREVALENCE AND DETERMINANTS OF CHRONIC OBSTRUCTIVE 
PULMONARY DISEASE 
The estimates of global all-age incidence of COPO are 9/1000 males and 
7.3/1000 in females and it is projected to become the third leading cause of 
death in the world by 2020.13,15 The increasing prevalence of COPO is 
attributed mainly to the increased use of tobacco products worldwide and up 











data on the determinants of COPO for sub-Saharan Africa with most studies 
focussing on the prevalence of chronic bronchitis. Most of these studies tend 
to be conducted among men in occupational settings in whom smoking is 
common.9 A review of several large population-based studies suggests that 
occupational exposures may account for a large proportion of either 
symptoms (median 15%; range 4-29%) or functional impairment consistent 
with COPO (median 19%; range 12-55%).1 Other factors implicated in the 
aetiology of COPO are air pollution, low socio economic status and 
endogenous risk factors such as male gender, genetic factors, presence of 
respiratory disease in childhood and family history.13 
A large multi-centric Indian study foclJssing on the epidemiology of COPO 
found the prevalence of COPO (presence of cough and expectoration on most 
days for at least three months in the year for two consecutive years or more) 
to be 4.1 % with a male: female ratio of 1.6: 1 and a smoker to non-smoker 
ratio of 2.7:1. Risk factors for COPO were found to be male sex, age, low 
socio-economic status and urban residence. 16 Similarly, in a large population 
based survey in South Korea that utilized spirometry to assess COPO 
prevalence (GOLO stage 1: FEV1/FVC<70%), reported a prevalence of 
COPO of 7,8% in all adults over the age of 18 years (men, 10.9%; women, 
4.9%) and 17.2% in adults over the age of 45 years (men, 25.8%; women, 
9.6%).17 Independent risk factors for COPO included age older than 65 years 
(OR, 4.05; 95%CI2.92-5.61), male sex (OR, 2.62; 95%CI, 1.64-4.18), more 
than 20 pack-years of smoking (OR, 2.81; 95%CI, 1.76-4.50), and low income 











The true prevalence of COPO in sub-Saharan Africa is unknown, however the 
risk factors which appear to be important for COPO are tobacco smoking, air 
pollution and respiratory infections, whilst in South Africa recognized factors 
contributing to the prevalence of COPO are tuberculosis, industrial and mining 
dust exposures and the domestic use of biomass fuels.15 In a nationally 
representative South African survey Ehrlich et a/ determined the prevalence of 
chronic bronchitis (cough with phlegm every day for at least 3 months a year 
for at least 2 consecutive years) to be 2.3% in adult males and 2.8% in 
women. Risk factors other than smoking that were found to be predictive of 
chronic bronchitis was a history of tuberculosis in men and women (men, OR, 
4.9; 95% CI; 2.6-9.2; women OR, 6.6; 95%CI, 3.7-11.9) occupational 
exposure in men (OR, 1.6; 95%CI, 1.0 - 2.6) and smoky domestic fuel in 
women (OR, 1.5; 95%CI, 1.0 -2.1). The population attributable fraction (PAF) 
was 25% for current smoking, 14% for occupational exposure and 10% for a 
past history of TB in men. Limitations of this study were in part due to the 
nature of the study design being that of a demographic and household survey 
that relied on self-reported symptoms of chronic bronchitis without more 
objective tests of lung function (spirometry and NSBH). There was also under 
representation of working people in the study sample.7 
1.2.3 SMOKING AND OBSTRUCTIVE LUNG DISEASE 
The relationship between smoking and obstructive lung disease is a complex 
one. The "Outch hypothesis" developed half a century ago, attempted to link 
atopy, asthma, smoking and COPO.19 The theory proposed that COPO 











underlying atopic diathesis. Further evidence in this regard is the presence of 
eosinophilic inflammation in the airways of those diagnosed with capo. A 
possible explanation is the presence of an atopic diathesis or pre-existing 
asthma in such individuals. Other researchers have associated the presence 
of eosinophilia with the presence of concurrent asthma in those with capo. 
Notwithstanding the complexity of the relationship between smoking and 
obstructive lung disease, an association between smoking and bronchial 
irritation, the precipitation of acute episodes, NSBH and increased 
sensitization to some occupational allergens have been demonstrated in 
adults with asthma.18 Whilst many large population studies have confirmed 
an association between NSBH and smoking, it is unclear whether this 
represents a causal association. Explanations for the association have 
centred on the propensity of smoking to unmask NSBH or aggravate pre-
existing NSBH.19 An epidemiological study on the genetics and environment 
of asthma (EGEA) has shown an association between smoking and severity 
of asthma but no clear relationship between smoking habits and asthma 
causation.2o 
1.2.4 AEROALLERGENS, ATOPY AND OBSTRUCTIVE LUNG DISEASE 
Whilst atopy is recognized as a strong predictor of asthma, the presence of 
allergen-specific IgE does not necessarily translate into clinical allergy as in 
asthma.21 Questions remain around the predictive value of sensitization as it 
pertains to number of allergens (monosensitization versus polysensitization) 
and type of aeroallergen sensitized to (indoor, pollen or mOUld). A recent 











suggests that a family history of atopy and polysensitization are more likely to 
be associated with symptoms of allergic disease and that mono- and 
polysensitized patients may differ in respect of their immune response.21 
A population-based Finnish study found the prevalence of atopy (positive to a 
least one aeroallergen on SPT) to be 46.9 % and demonstrated an inverse 
relationship between atopy and age among adults 26-60 year of age. 22 
Polysensitization (sensitization to at least four aeroallergens) was more 
common in the younger age group (42%) than in the older (> 50 years) group 
(16%)( p<0.001). Furthermore sensitization to multiple allergens was 
associated with a high prevalence of asthma, allergic rhinitis or conjunctivitis 
and wheeze. A large US-based population study reported an even higher 
prevalence rate for atopy (54.3%) in those aged 6-59 years with the 
prevalence to at least one indoor allergen being slightly higher than that to 
one outdoor allergen (43% versus 40%). Sensitization occurred most 
commonly to house dust mite, ragweed, perennial rye grass pollen and 
German cockroach.23 
Little is known about the patterns of allergen sensitization and the relationship 
between atopy and asthma in sub-Saharan African adults.9 Sensitization to 
indoor allergens such as house dust mite and cockroach, inner-city residence, 
low position in sib-ship were found to be independent risk factors for asthma 
in Ghanaian children whilst a recent East African study in adult women 
revealed no relationship between atopy and asthma. In Africa the presence of 
parasitic diseases may be a confounding factor and some studies suggest 













in atopic individuals.9 The increase in allergic diseases in the industrialized 
world has often been explained by a decline in infections during childhood 
causing a skewed Th2 response as expounded by the" hygiene hypothesis 
(Figure 2).24 
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Figure 2 Diagram depicting the relationship between infectious environment during childhood 
and the alteration of Th1 and Th2 reponses to innocuous antigen 
Source: Romagni SJ. Allergy Clin ImmunoI2000;105:399-408 
Studies looking at the relationship between atopy and COPO have tended to 
focus on lung function decline as an indicator of COPO and have been 
complicated by the difficulty in distinguishing clearly between subjects with 
asthma and COPO. Skin test reactivity to common aeroallergens has been 
shown to be a significant predictor of the annual rates of decline in FEV1 and 
FEV1/FVC in an occupational cohort (N=1 025) even after adjusting for the 











decline in lung function, independent of the effects of cigarette smoke in those 
with COPD. 
1.2.5 DIETARY POLYUNSATURATED FATTY ACIDS (PUFAs), 
INFLAMMATION AND OBSTRUC"nVE LUNG DISEASE 
1.2.5.1 The role ofPUFAs in inflammatory disease 
Patterns of the consumption of the long chain n-3 and n-6 fatty acids have 
been demonstrated to be associated with the development of airway 
inflammation (Figure 3). The most abundant n-6 PUFA in the western diet, 
linoleic acid (18:2n-6), is converted to arachidonic acid, a precursor of both 
prostaglandin E2 and leukotriene 84, both of which have proinflammatory 
biologic actions. In contrast, alpha linolenic acid (18:3n-3) an n-3 PUFA is 
converted to eicosapentaenoic acid (20:5n-3), which can inhibit arachidonic 
acid and thereby suppress production of the n-6 eicosanoid inflammatory 
mediators.26 In the typical Western diet 25-fold more omega n-6 PUFAs than 
n-3 PUFAs are consumed.27 It is suggested on this basis that changes in 
dietary patterns in developed countries could partly explain the increase in the 
prevalence of asthma. The omega n-3 PUFAs are found in high quantities in 
fish oil and monounsaturated oils such as canola and "tlaxseed oils, whereas 
n-6 PUFA are present in polyunsaturated fats such as soybean, corn, 











Synthesis of Eicosanoids From  
Omega-6 and Omega ..3 Fatty Acids  
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Figure 3 Diagram depicting the synthesis of eicosanoids from omega-6 and omega-3 fatty 
acids 
Source: Din IN, Newby DE, Flapan AD. Omega-3 fatty acids and cardiovascular disease-
fishing for a natural treatment BMJ 2004;328:30-35 
1.2.5.2 Correlation between serum fatty aid and dietary intake 
In examining the relationship between fatty acids and respiratory outcomes, 
most studies have reported on the frequency of dietary intake of fish I seafood 
as reported by study subjects.28 A strong correlation between habitual fish 
intake and serum eicosapentaenoic acid (EPA) and docosapentaenoic acid 
(DPA) levels has been shown suggesting that serum concentrations of n-3 
fatty acids are useful as biomarkers for dietary fish intake.29,30 Plasma n-3 
concentrations have been found to be significantly higher in women than in 
men, 20% higher in fish-oil consumers versus non-fish-oil consumers and 











1.2.5.3 PUFAs and respiratory health 
Studies examining respiratory health effects related to dietary intake of fatty 
acids have produced inconclusive results. Fish intake viewed as an indicator 
of n-3 PUFA intake has been associated with beneficial effect on lung 
function, but the relationship with clinically evident asthma or COPO is less 
impressive.28 Other studies have demonstrated that a diet high in marine n-3 
PUFA (fish oil) may have beneficial effects on airway hyperresponsiveness 
and that fish oil supplementation may reduce the severity of exercise-induced 
bronchoconstriction in adults.27 While most studies have relied on self-
reporting of dietary intake to estimate n-3 PUFA intake, a recent study looking 
at serum fatty acid levels and asthma outcomes in young adults have 
demonstrated a consistent association between the 20:3n-6 PUFA Oihomo 
gamma-linoleic acid (OHGLA) and 20:2 n-6 PUFA and asthma outcomes. 
Higher OHGLA levels were also found in those who reported suffering a 
recent asthma attack.31 In a prospective study of adult-onset asthma, high 
margarine intake and high intake of oleic acid (18:1 n-9) has also been shown 
to be positively associated with asthma symptoms.32 
The relationship between COPO and dietary fat intake has demonstrated 
inconsistent results and has been very vulnerable to confounding factors. 
A significant beneficial association has been demonstrated between fish 
intake and the prevalence of COPO among former and current smokers.28 
These results raise interesting questions around the role of dietary fats in 












1.2.6 OCCUPATION AND OBSTRUCTIVE LUNG DISEASE  
Work-related factors are responsible for up to one third of all asthma cases 
(Attributable fraction, 29%; 95% CI, 25-33%).33 The important role of 
occupation as a risk factor for the development of obstructive lung disease 
has therefore been recognized globally and the median population attributable 
fraction for asthma and chronic obstructive pulmonary disease is estimated to 
be 15%.1.33,34.35 In a large South African population survey the population 
attributable fraction of asthma due to occupational factors was estimated to be 
13% whilst a recent review of occupational asthma (OA) reported the 
incidence of OA in SA to be 1.7/100000.6 Work-related asthma comprises 
asthma caused by specific agents in the workplace (OA) as well as pre-
existing asthma aggravated by workplace exposures. Occupational exposures 
contribute to asthma through specific exposures to sensitizing agents or 
respiratory irritants in the workplace.1. 6 Over 250 agents have been identified 
and documented to cause sensitizer-induced occupational asthma whilst the 
mechanisms underlying irritant-induced asthma are less well understood.1 1 In 
allarge population-based study, the National Health and Nutrition 
Examination Survey (NHANES), Arif et al demonstrated a more than 2-fold 
increase in work-related asthma (yes to "has a doctor ever told you that you 
had asthma" and "are any of the symptoms: wheezing, whistling, stuffy, itchy 
or runny nose, watery, itchy eyes brought on by work environment") in the 
agriculture, forestry and fishing industry (OR 2.94,95% CI, 0.95-9.15). 
Furthermore a significantly increased risk in the prevalence of work-related 













work-related symptoms) was also observed in this industrial group of workers 
(OR 2.67, 95C11.44 -4.97), suggesting that workers in the fishing industry 
among others are at increased risk of developing asthma.34 A review of 
occupational asthma in the seafood industry indicated a prevalence of 
6_36%.36 Jeebhay et al has reported an occupational asthma prevalence of 
3% in seafood processing workers in the Western Cape province of South 
Africa. 37 This is based on analysis of the current data set which forms the 
basis for this current study. 
In summary given that known risk factors such as smoking, atopy and NSBH 
only account for a proportion of cases of obstructive lung disease, and the 
growing body of evidence mainly in industrialized countries implicating 
occupational factors in the aetiology of both asthma and COPD, further 
research is needed to assess the extent to which these associations also 
pertain to developing countries in general and to South Africa in particular.1,6 
15  












To determine the patterns of and the factors associated with obstructive lung 
disease in a population of seafood processing workers on the West Coast of 
the Western Cape Province of South Africa. 
1.4 OBJECTIVES 
» To describe the demographic profile of seafood processing workers 
living in a fishing village along the West Coast of the Western Cape 
Province 
» To describe the prevalence of the major patterns of obstructive lung 
disease (asthma and chronic obstructive pulmonary disease) in this 
population 
» To describe the factors associated with obstructive lung disease 
(asthma and COPO) with specific reference to host (age, gender, 
allergic history, smoking history and previous history of lung disease) 
and environmental (occupational exposures) 
» To estimate the population attributable fraction of selected risk factors 
in relation to the burden of obstructive lung disease (asthma and 
COPO) in this population 
» To conduct a detailed analysis of allergic sensitization profiles to 
common allergens (using skin prick tests) in the study population and 
their relationship with asthma outcomes 
» To conduct a detailed analysis of seafood intake and serum fatty acid 
















CHAPTER TWO: METHODOLOGY 
2.1 STUDY DESIGN, POPULATION AND SAMPLING 
This study data set was obtained from a cross-sectional study which was 
originally designed to specifically determine the prevalence and risk factors for 
occupational asthma due to fish allergens among seafood processing 
workers.37 This current study has focussed more broadly on the 
environmental and host predictors of obstructive lung disease among working 
adults of a fishing village along the West coast of South Africa. The study 
population comprised 643 currently employed workers of two fish-processing 
plants in St. Helena Bay. In one plant all 260 workers were included in the 
study and, for efficiency reasons, a stratified random sample was drawn from 
the other plant which constituted 383 workers from a total workforce of 1275. 
2.2 HEALTH OUTCOME MEASUREMENTS 
2.2. 1 Questionnaire 
Each worker answered a standard questionnaire specifically designed for the 
investigation of respiratory health according to the protocol for the European 
Community Respiratory Health Survey. 38 It addressed acute and chronic 
work-related respiratory symptoms and a history of previous medical illnesses. 
Modifications were also made to include questions on seafood aerosol 
exposure, tobacco smoke exposure and patterns of seafood ingestion. 
Occupational exposure indices were developed from self-reported exposures 
obtained from the questionnaire. A more detailed exposure-response 
evaluation based on objective exposure characterization is the subject of 
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another study.37 The questionnaire was adapted for local conditions and 
translated into Afrikaans and Xhosa and back translated to assess validity and 
reproducibility. It was administered by trained interviewers in the respondent's 
language of choice. 
2.2.2 Skin prick test (SPT) 
Skin prick tests (SPT) were performed on each worker using a battery of 
standard common local aeroallergens that included house dust mite 
(Dermatophagoides Pteronyssinus), bermuda grass (Cynodon dactylon), rye 
grass (Lolium perenne) , cockroach (Blatella germanica), cat (Felis 
domesticus), dog (Canis familiaris), mouldmix (Cladosporium herbarum, 
Altemaria altemata, Fusarium) and Aspergillus (Aspergillus fumigatus). 
Histamine dihydrochloride was used as a positive control and a diluent of 
glycerol/sodium chloride as a negative control. Atopic status was defined as a 
positive SPT to anyone of the common aeroallergens.39 A positive result was 
considered as a SPT of 3mm in comparison to the negative control. 
2.2.3 Serum determination ofomega-3 and omega-6 fatty acids 
All workers had blood samples taken for analysis of n-3, n-9 and n-6 fatty acid 
content as % weight of phospholipids. Analysis of the samples was carried out 
by the Nutritional Intervention Research Unit of the Medical Research Council. 
For serum determinations of omega fatty acids, plasma was thawed and 
extracted with chloroform/methanol. All the extraction solvents contained 
0.01% butylated hydroxytoluene as an antioxidant. Heptadecanoic acid 











Neutral lipids were separated from total phospholipids by thin layer 
chromatography on pre-coated silica gel 60 plates without a fluorescent 
indicator using a solvent system. The lipid bands were visualized with 
longwave ultraviolet light after spraying the plates with chloroform/methanol. 
The total phospholipid and was scraped off and analyzed for fatty acid 
composition. The levels of individual fatty acids were measured and the 
results expressed as a percentage weight of total phospholipid. 
2.2.4 Spirometry 
American Thoracic Society (ATS) guidelines were followed when conducting 
spirometry.40 Vitallograph S model bellows volume-time spirometers, 
calibrated at least twice daily, were used for performing spirometry. 
Technologists who had undergone training in standard technique conducted 
the spirometry. The technologists were blinded to the exposure status of each 
worker. Spirometry was performed in a sitting position without nose clips. 
Each worker performed up to eight trials to produce three acceptable curves. 
The lung function indices of primary interest included forced vital capacity 
(FVC) and forced expiratory volume in one second (FEV1). The best FEV1 and 
FVC were used regardless of whether they belonged to the same tracing. 
Lung volumes obtained by spirometry were adjusted for body temperature and 
pressure according to the temperature and atmospheric pressure measured 
on a continuous basis throughout the day. Heights of workers were recorded 
for calculating predicted lung function indices using reference values of the 
European Community for Coal and Steel (ECCS) with lower limits 











contra-indications were present: subject was pregnant, epileptic, recent (3 
months prior) stroke or heart attack, recent (3 weeks prior) respiratory tract 
infection or TB diagnosis. 
2.2.5 Methacholine challenge test 
Non-specific inhalation challenge testing was performed on all workers (except where 
contra-indicated) by trained technologists according to an abbreviated protocol used in 
epidemiological surveys. The two-minute tidal breathing method, with incremental 
concentrations of methacholine, as outlined by the recent American Thoracic Society 
guidelines adapted for local conditions was used. 41 In all subjects eligible for 
methacholine challenge test (MCT), saline diluent was first administered as a control 
to ensure that the FEV1did not increase by >10% from baseline. Inhalations were 
done every five minutes while the subject was seated and had a nose-clip. Subjects 
then underwent either a short, medium or full protocol depending on symptoms and 
degree of lung function impairment at baseline. If the initial FEV1 was 70-80% of 
predicted or the subject had current symptoms of airway obstruction, concentrations 
commencing at 0.03mg/ml and doubling concentrations to 16mg/ml were used (long 
protocol). If subjects had a positive history of asthma or symptoms that were controlled 
and an initial FEV1 80% of predicted, concentrations of 0.12Smg/ml doubling to 
16mg/ml were used (medium protocol). If subjects had no symptoms or history of 
asthma and initial FEV1 80% of predicted, concentrations of 2,4,8 and 16mg/ml 
were used (short protocol). A positive methacholine challenge test with a PC20 :;;; 8 












Specific contraindications for MCT included breast feeding, elevated blood 
pressure (>180/110), subjects with either FEV1 <1.SL or FEV1 < 70% of the 
predicted mean value or a subject with acute asthma symptoms at the time of 
testing. In such cases a bronchodilator (400 IJg salbutamol) was administered 
by metered dose inhaler (MOl) instead. A change in FEV1 of % after 10 
minutes of bronchodilator administration was considered indicative of the 
presence of NSBH. All workers who underwent methacholine challenge were 
also given a bronchodilator and their lung function tested until the post-
bronchodilator FEV1 was >90% of the initial FEV1. Other special precautionary 
measures included oxygen and B2-adrenergic agents, which were readily 
available for nebulization. 
2.3 DATA MANAGEMENT AND ANALYSIS 
The main respiratory outcome of interest was the presence of obstructive lung 
disease focussing particularly on asthma and COPO outcomes. Explicit 
definitions were employed with asthma and COPO outcomes based on 
validated questions reporting symptoms, spirometry, and tests for NSBH and / 











2.3.1 Definitions for asthma-related outcomes 
1. Atopy: A positive SPT with a wheal read 15 minutes after testing that had a 
diameter (mean of two perpendicular measures) of ;::: 3 mm more than the 
negative control to any allergen 
2. Asthma symptoms: yes to any of: "Have you had an attack of asthma in 
the last 12 months?", "Have you been woken by an attack of shortness of 
breath in the last 12 months?", "Have you been woken up with a feeling of 
tightness in your chest any time in the last 12 months?" 
3. Current asthma: Self-reported wheeze in the past 12 months and the 
presence of NSBH 
4. Doctor-diagnosed asthma: yes to both questions: "Have you ever had 
asthma?" and 'Was this confirmed by a doctor?" 
5. Non-specific bronchial hyperresponsiveness: A positive methacholine 
challenge test with a PC20 ::;; 8 mg/ml causing a drop in FEV 1 of 20% or more 
or an increase in FEV1 of ;:::12 % after 10 minutes of bronchodilator 
administration on baseline spirometry, was considered indicative of the 
presence of NSBH. 
2.3.2 Definitions for COPD-related outcomes 
1. Chronic bronchitis symptoms: Reporting a chronic productive cough for 
3 months in 2 or more consecutive years 
2. Airway obstruction: FEV1/ FVC < 70% 
3. Fixed airway obstruction: FEV1 / FVC < 70% and absence of NSBH 











2.3.3 Demographic, medical and occupational variables as predictors 
Predictor variables pertained to sociodemographic factors, environmental and 
occupational exposures and past medical history. 
Sociodemographic variables included in the study were those of age, 
sex, atopy and employment status (permanent/seasonal/casual) 
Past medical history included a history of previous tuberculosis, chronic 
bronchitis, recurrent chest infections during childhood, history of 
allergic disease and treatment for such a disease 
Exposure variables included smoking, occupational exposures and 
consumption of seafood in the diet. 
2.3.4 Analysis of data 
The data was analysed using Stata, version 8. Data analysis focussed on the 
relationship between the independent variables and the diagnosis of 
obstructive lung disease (asthma and COPD) to ascertain which factors best 
predicted the presence of disea e. Univariate analysis summarized the 
distribution of each measured variable. Bivariate analysis was employed to 
assess the nature of the associations between outcomes, exposures and 
covariates. Each coefficient estimate is represented from a separate bivariate 
model. Multiple logistic regression models were developed to assess the 
exposure effects on health outcomes. Confounding and effect modification by 
covariates were considered and adjusted for in the formulation of the models. 
Each coefficient estimate is represented from a separate multivariate model 
containing the variable of interest and confounding variables. The population 
attributable fraction in respect of selected variables was calculated for the 
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diagnosis of asthma and COPO in accordance with the following formula. 
Population attributable fraction: p (POR-1) I [p (POR -1) + 1 where POR = 
prevalence odds ratio as an estimate of the relative risk and p =prevalence of 
the risk factor in the population. 
2.4 ETHICS 
Ethical approval was obtained for the original study which focussed on the 
prevalence and determinants of occupational asthma due to seafood 
exposure. Since no new data was collected and anonymity was preserved 
during this study, the requirement for renewed ethics application in respect of 
this study was waived by the Post-graduate dissertation committee of the 













CHAPTER THREE: RESULTS 
3.1 DEMOGRAPHIC AND MEDICAL CHARACTERISTICS 
The study population comprised 643 workers from two seafood processing 
factories. All were interviewed by questionnaire. 626 subjects underwent 
skinprick tests (SPT) and 582 underwent spirometry, whilst a further 542 
were assessed for the presence of NSBH. The study subjects had a mean 
age of 35 years. The majority of workers were female (65%) (see Table 3.1). 
A high prevalence of smoking was found with 327 (51%) workers current 
smokers at the time of the survey. The population also reported a high 
prevalence of previous respiratory disease with 13% having been treated for 
tuberculosis in the past. Although a large proportion (23%) reported suffering 
from ocular nasal symptoms very few (2%) were receiving medical treatment 
for symptoms of allergic disease such as asthma or allergic rhinitis at the time 
of the survey 
3.2. OCCUPATIONAL AND ENVIRONMENTAL EXPOSURE 
CHARACTERISTICS 
Examination of the occupational characteristics revealed that the majority of 
workers (70%) were seasonal workers (see Table 3.2). There were 420 (65%) 
workers who reported having experienced some occupational exposure to 
steam, gases, dust or fumes with 38% describing such exposure as excessive 
whilst 19% reported experiencing adverse respiratory symptoms as a result of 
episodic peak occupational exposures. A high percentage of workers reported 
suffering either tight chest or wheeze (15%) or ocular-nasal symptoms (27%) 











Of those who had experienced an asthma attack in the preceding year 4% 
cited the precipitating factor to be an exposure to dust or sprays at work. 
Other environmental factors triggering asthma attacks were changes in the 
weather (6%), exercise (5%) and exposure to tobacco smoke (4%). 
Table 3.1 Demographic characteristics of seafood processing workers 
along the West Coast of the Western Cape 
Demographic characteristics 	 Prevalence 












Past medical history 
Previous treatment for tuberculosis 
Previous treatment for chronic bronchitis 
Previous treatment for recurrent chest infections in 
childhood 
History of allergic disease 
No. with ocular-nasal symptoms 
No. with hayfever in childhood 
No. on current asthma treatment 
No on current hayfever treatment 
34 ± 10.67 
34 ± 9.66 






















Table 3.2 Occupational characteristics and environmental triggers of 
respiratory symptoms in seafood processing workers along the West 
Coast of the Western Cape 
Occupational characteristics and exposures Prevalence 
(N=643) 




Occupational exposure to steam, gasses, dust or 
fumes 
Extent of occupational exposure to dust, mist spray 





Episode of peak exposure causing wheezy chest or 
cough 
Work-related chest symptoms 
Work-related ocular-nasal symptoms 
Environmental triggers of recent asthma attack 
Changes in the weather 
Strenuous exercise 
Dust or sprays at work 
Tobacco smoke 
Breathing in cold air 
Grass or flowers 






























3.3 SEAFOOD INTAKE AND SERUM FATTY ACID PROFILES 
Questions on dietary history that focussed on fish and seafood consumption 
revealed high levels of frequent (>once/month) fish (94%) and squid (58%) 
consumption among the study population (Table 3.3). Whilst many workers 
reported consuming rock lobster/prawns (73%) and oyster/mussels (64%) this 
did not occur with the same frequency of intake as for fish and squid. 
Table 3.3 Recent seafood dietary intake (N=642) of seafood processing 
workers along the West Coast of the Western Cape 
Type and frequency of Frequency (%) Frequency of 
seafood dietary intake consumption (%) 
In the past year (N=642) 




















































Laboratory analysis of serum fatty acids analyzed specifically for serum levels 
of polyunsaturated fats (PUFAs) of the omega 3 (n-3) and omega 6 (n-6) in 
633 subjects (Table 3.4). Linolenic acid (LA), arachidonic acid (AA) and 
dihomogamma-linoleic acid (DHGLA) had the highest mean serum levels as a 
% weight of total phospholipids among the n-6 PUFAs. Docosahexaenoic acid 
(DHA) and eicosapentaenoic acid (EPA) had the highest mean serum levels 
among the n-3 PUFAs. The mean ratio of total n-6 to n-3 was high (3.71). 
Table 3.4 Serum fatty acid profile (N=633) as a percentage weight of total 
phospholipid among seafood processing workers along the West Coast 
of the Western Cape 
Type of fatty acid Mean serum Weight % 
fatty acid level phospholipid 
IIg I ml Mean (SO) 
n-6 series polyunsaturated 
18:2 Linolenic acid (LA) 
18:3 Gamma- linolenic acid (GLA) 
20:2 
20:3 Dihomo gamma-linoleic acid 
(DHGLA) 
20:4 Arachidonic acid (AA) 
22:2 
22:4 
n-3 series polyunsaturated 
18:3 Alpha-linolenic acid (ALA) 
20:0 
20:5 Eicosapentaeoic acid (EPA) 
22.5 Docosapentaenoic acid (DPA) 
















































3.4 ALLERGIC SENSITIZATION ON SKIN PRICK TESTING  
A substantial proportion of the population were atopic (37%) on skinprick 
testing with sensitization to indoor aeroallergens such as house dust mite 
(25%) and cockroach (15%) being the most prevalent (See Table 3.5). Most 
subjects were sensitized to three or less allergens (32%) and a similar number 
displayed sensitization to at least one of the indoor aeroallergens (HOM, 
cockroach, cat, dog). Sensitization to the mould group of allergens was low 
(5%). 
Table 3.5 Allergic sensitization profiles of seafood processing workers 
along the West Coast of the Western Cape 
Sensitization variables Prevalence (%) 
(N=626) 
All aeroallergens 
Atopy (Positive to at least one aeroallergen) 
Positive to one aeroallergen 








No with one to three aeroallergens 
positive 
No with greater than three aeroallergens 
positive 
At least one indoor allergen (HOM, 
cockroach, cat, dog) positive 
At least one pollen allergen (bermuda 
grass, rye grass) 


























3.5 PULMONARY FUNCTION AND NON-SPECIFIC CHALLENGE TESTS  
Among the 582 workers who underwent spirometry, 543 proceeded to 
challenge tests (either methacholine or bronchodilator challenge) to assess for 
the presence of NSBH. Reasons for exclusion from NSBH testing were mainly 
related to pre-existing contraindications stipulated in the protocol (recent 
abdominal I chest surgery, epilepsy, pregnancy, current use of beta-blockers, 
elevated blood pressure and recent respiratory tract infection). A further 9 
workers were unable to perform spirometry despite 8 attempts. Of those who 
proceeded with MCT 278 (61%) followed the short protocol, 108 (24%) the 
medium protocol and 68 (15%) the long protocol. The results of pulmonary 
function and non-specific bronchial challenge tests are presented in Table 3.6. 
Whilst 29% of workers had an initial FEV1 < 80% of predicted values, only 5% 
had evidence of airway obstruction (FEV1/FVC, 70%) and 12 % had a post-
bronchodilator FEV1<80% of predicted. Males were more likely than females 
to demonstrate evidence of airway obstruction (OR, 4.09; 95% CI, 1.89 -
8.86). A total of 141 (26%) tested positive for NSBH whilst the test was 
discontinued in 23 subjects due to a decline in FEV1 of >10% after 
administration of saline diluent. Females were more likely to display NSBH 
than males as evidenced by a positive methacholine challenge test (OR, 2.71; 











Table 3.6 Pulmonary function and non-specific bronchial challenge test 
outcomes among seafood processing workers along the West Coast of 
the Western Cape 
. Pulmonary function Overall Male Female P-value 
indices N=582 N=208 N=374 
FEV1(Iitres) 2.76 (0.74) 3.31 2.45 (0.50) <0.001* 
(0.80) 
I FVC (Iitres) 3.28 (0.86) 4.04 2.84 (0.56) <0.001* 
(0.79) 
FEV1% predicted 87± 14 87 ± 16 87 ± 14 0.859* 
FVC % predicted 88 ± 13 89 ± 13 87 ± 13 0.264* 
FEV1/FVC 84±8 81 ± 10 86±7 <0.001* 
No. with FEV1/FVC < 70% 31 (5%) 21 (10%) 10 (3%) <0.001** 
(absolute) 
No. with initial FEV1< 80% 167 (29%) 54 (26%) 113 (30%) 0.277 ** 
predicted 
No. with post- 68 (12%) 25 (12%) 43 (12%) 0.977 ** 
bronchodilator FEV1<80% 
predicted 
No. with evidence of (N=543) (N=200) (N=343) 
bronchial 
hyperresponsiveness 
No. with;:: 12% FEV1 12 (2%) 3 (2%) 9 (3%) 0.750*** 
increase post 
bronchodilator (no =89) I 
No. with;:: 10% FEV1 23 (4%) 6 (3%) 17 (5%) 0.254** 
decrease post saline 
diluent (nc =477) 
No. with;:: 20% FEV1 129 (24%) 27 (14%) 102 (30%) <0.001** 
decrease to methacholine 
at 8mg/ml (nc = 454) 54 (10%) 
-short protocol (nc =278) 41 (8%) 11 (6%) 43 (13%) 0.001** 
-medium protocol 8 (4%) 33 (10%) 0.012** 
(nc= 108) 34 (6%) 
-long protocol (nc = 68) 8 (4%) 26 (8%) 0.024** 
Continuous variables-mean ± SO; CategOrical variables-number (%); nc: number completed 
test; 
Reference values are from the European Community for Coal and Steel (ECCS), 1993. 
*Two-sample t-test 
*'* Chi-square test with 1 degree of freedom 











3.6 ENVIRONMENTAL AND HOST FACTORS ASSOCIATED WITH  
ASTHMA OUTCOMES 
3.6.1 Host factors 
The prevalence of four asthma-related outcomes was considered (Table 3.7). 
There were 11 % with the presence of self-reported asthma symptoms (yes to 
any of: "Have you had an attack of asthma in the last 12 months?", "Have you 
been woken by an attack of shortness of breath in the last 12 months?", "Have 
you been woken up with a feeling of tightness in your chest any time in the 
last 12 months?"). Twenty six percent had NSBH (defined as a positive 
methacholine challenge test with a PC20::;; 8 mg/ml causing a drop in FEV1 of 
20% or more or an increase in FEV1 of % after 10 minutes of 
bronchodilator administration ). There were 5% with current asthma (Self-
reported wheeze in the past 12 months and NSBH) and 7% with doctor-
diagnosed asthma (yes to both: "Have you ever had asthma?" and "Was this 
confirmed by a doctor?" The latter two diagnostic categories were considered 
to have greater specificity than the former two. 
In the unadjusted logistic regression models, increasing age was significantly 
associated with asthma symptoms (OR, 1.03; 95%CI, 1.00-1.05) and current 
asthma (OR, 1.04; 95%CI, 1.01-1.07) whilst female gender was significantly 
associated with NSBH (OR, 2.17; 95%CI, 1.73-4.25) (Table 3.7). Atopy was 
strongly and positively associated with all asthma outcomes, the association 
being strongest for current asthma (OR, 3.42; 95% CI, 1.S2-7.24).There was 











Previous treatment for chronic bronchitis (OR, 5.82; 95% CI, 2.66 -12.73) or 
recurrent chest infections in childhood (OR, 8.91; 95% C13.74 - 21.22) were 
strongly associated with current asthma and were generally significant 
predictors for all asthma outcomes. This was not the case for those who had 
reported having received treatment for tuberculosis in the past. As expected, a 
history of hay fever and being on asthma treatment were consistently 
associated with all asthma outcomes. In the multivariate analysis a history of 
having been previously treated for chronic bronchitis, recurrent chest 
infections in childhood or being on asthma treatment remained significantly 
associated with all asthma outcomes after adjusting for age, gender, atopy 
and smoking (Table 3.8). Pre-existing morbidity due to respiratory diseases 
such as chronic bronchitis and recurrent chest infections in childhood 
accounted for 29.9% and 42.5% respectively of the population attributable 
fraction for current asthma cases. 
3.6.2 Occupational characteristics and exposures 
Examination of the impact of occupational status revealed that seasonal 
workers were less likely to report suffering from asthma symptoms (OR, 0.60; 
95% CI, 28 - 0.95) but were more likely to test positive for NSBH (OR, 1.63; 
95% CI, 1.04 - 2.56) (Table 3.7). A self-reported general history of 
occupational exposure to workplace agents and degree of exposure were not 
related to asthma outcomes. However, those who specifically reported 
episodes of peak exposure to workplace agents were more likely to have 











from tight chest or wheeze in relation to peak exposures was strongly 
associated with current asthma (OR, 8.98 95% CI, 4.33 - 18.63). After 
adjusting for potential confounders in the multivariate models, the 
occupational factors that continued to show an association with general 
asthma outcomes were peak occupational exposures, work-related ocular-
nasal symptoms and work-related chest symptoms (Table 3.8). 
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3.6.3 Allergic sensitization profiles 
In the logistic regression models, being atopic or sensitized to house dust mite 
was strongly associated with all asthma outcomes (OR, 2.89; 95% CI, 1.40-
5.93 for current asthma), whilst sensitization to cockroach was only 
associated with NSBH (OR, 1.89; 95%CI, 1.15 - 3.12) and current asthma 
(OR, 2.35; 95%CI, 1.05 - 5.25) (see Table 3.9). This was also reflected in the 
group allergen profile with sensitization to anyone of the indoor allergens 
showing a consistent positive association with asthma. Sensitization to three 
or less allergens was associated with asthma symptoms, current asthma and 
doctor-diagnosed asthma whilst sensitization to more than three allergens 
was more likely to predict NSBH. While sensitization to the pollen and mould 
group of allergens was associated with doctor-diagnosed asthma and asthma 
symptoms respectively, they appeared to be less important a predictor of 
asthma in this population. Notably this was not the case for Aspergillus 
sensitization which was strongly associated with asthma symptoms (OR, 5.02; 
95%CI,1.63 -15.45) and with doctor-diagnosed asthma (OR, 3.90; 95%CI, 
1.05 -14.54). 
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3.6.4 Seafood intake and polyunsaturated fatty acid (PUFA) profiles 
In the unadjusted and adjusted logistic regression models consumption of 
rock lobsterl prawns (OR, 0.52; 95%CI, 0.31- 0.86) and oyster (OR, 0.58; 
95%CI, 0.36-0.96) appeared to be protective against the development of 
asthma symptoms, whilst consumption of other types of seafood did not 
impact on asthma outcomes (Table 3.10). Among the n-6 PUFAs, 18:21 LA 
(OR, 1.14; 95% CI, 1.08 -1.21) and 20:31 DHGLA (OR, 1.67; 95% CI, 1.27 -
2.20) were positively associated with NSBH. The n-6 PUFA 22:2 had a 
protective association with respect to asthma outcomes that was significant 
for NSBH (OR, 0.29; 95%CI, 0.10-0.87). However, none of the fatty acids 
showed any association with atopy. After adjusting for age, gender and 
smoking the n-6 PUFA'S LA, DHGLA, and AA were all positively associated 
with the presence of NSBH (Table 3.11). In addition AA also showed a 
positive association with doctor-diagnosed asthma. The n-9 PUFA 18:1, n-6 
PUFA 22:2 and n-3 PUFAs EPA and DPA demonstrated a protective effect on 
NSBH after adjusting for age, gender and smoking. 
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3.7 HOST FACTORS AND OCCUPA1"IONAL EXPOSURES ASSOCIATED 
WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE OUTCOMES 
The four COPD-related outcomes considered were those of chronic bronchitis 
("yes to reporting a chronic productive cough for three months in two 
consecutive years"); FEV11 FVC <70% (evidence of airway obstruction); FEV1 
I FVC <70% and absence of NSBH (evidence of fixed obstruction); and 
FEVl FVC <70% and post-bronchodilator FEV1 < 80% predicted (definitive 
COPD according to South African Thoracic Society (SATS) guideline).15 The 
prevalence of chronic bronchitis was 3% whilst 5% displayed evidence of 
airway obstruction and 3% had fixed irreversible obstruction. There were 3% 
who had COPD according to the SATS guideline. In the unadjusted logistic 
regression models increasing age was associated with COPD outcomes 
whilst female gender was protective for all COPD outcomes except for chronic 
bronchitis symptoms (Table 3.12). Surprisingly, there was no association 
between smoking and any of the COPD outcomes despite the high 
prevalence of smoking in this population. Stratification to examine for possible 
effect modification by gender or age did not influence these findings (data not 
shown). 
Multivariate logistic regression analysis revealed that a past medical history of 
TB treatment was Significantly and positively associated with all COPD 
outcomes except for chronic bronchitis symptoms (Table 3.13). A history of 
recurrent childhood infections was also strongly predictive of COPD outcomes 











(FEV11 FVC <70%) (OR, 19.65; 95% CI, 6.35 - 60.81). A history of ocular-
nasal symptoms as well as being on current hayfever treatment were strongly 
associated with chronic bronchitis symptoms, whilst being on asthma 
treatment was associated with both chronic bronchitis symptoms and 
evidence of current airway obstruction (FEV1/FVC<70%). Among the 
occupational factors chest symptoms due to episodes of peak occupational 
exposures was associated with a six-fold increase in the odds of having 
chronic bronchitis symptoms (OR, 6.23; 95% CI 2.42 -16.04) whilst work-
related ocular-nasal symptoms was associated with a fourfold increased odds 
(OR 4.22, 95%CI, 1.64 - 10.87). The effect on chronic bronchitis symptoms 
was strongest for those who experienced tight chest or wheeze as a result of 
workplace exposures (OR, 11.34; 95% CI, 4.24 - 30.31). The PAF for TB and 
recurrent chest infections in childhood in relation to fixed airway obstruction 
were 20.1 % and 51.2% respectively_ 
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CHAPTER FOUR: DISCUSSION 
This study allowed for the examination of the determinants of obstructive lung 
disease in a working population using self-reported symptoms, spirometry 
and non-specific challenge tests to develop outcome variables for asthma 
and COPO. This resulted in a more accurate estimate of the prevalence of 
obstructive lung disease in a geographic subpopulation (Western Cape) in 
South Africa and more detailed analysis of the determinants of these disease 
outcomes in this population. 
Whilst most studies have identified occupational exposure as an important 
and significant predictor of obstructive lung disease. little is known about its 
prevalence in the South African working population outside the mining 
industry and the contribution of the various risk factors to the disease burden. 
Examination of the relationship of host factors, occupational exposures, 
allergic sensitization and dietary consumption of polyunsaturated fatty acids 
to obstructive lung disease, enabled the quantification of attributable burden 
of some of these risk factors. The findings of this study should lead to greater 
understanding of the role and contribution of the various risk factors to the 
obstructive lung disease burden and inform preventative strategies aimed at 
reducing the morbidity and mortality associated with these conditions. 
It is generally well recognized that there is considerable overlap between 
asthma and COPO with respect to symptomatology, treatment and diagnosis 
from both the patient and physician perspective.2,15 The prevalence for 











was remarkably consistent at 3 - 5% across all COPO outcomes. This 
prevalence for COPO is slightly higher than that found by Ehrlich et al in the 
large population-based study of South African adults (P, 1.5% in men; P, 1.9% 
in women). 7 However this may be related to the age structure of the 
population as the national survey included a large proportion of young adults 
between the ages of 15-23 which is lower than the average age of subjects in 
this current study (mean, 34 years). 
Our study also found a significantly higher percentage of men versus women 
(10% versus 3%) with evidence of obstructive lung disease (FEV1/FVC <70%) 
which is in keeping with the results of other studies in developing 
countries. 16.17 There was also a clear sex difference with respect to the 
prevalence of NSBH, being twice as common in women compared to men (P, 
30% in women; P, 14% in men). The association between female sex and 
NSBH has also been reported in a recent South African study by van 
Schalkwyk et al (OR, 3.6; 95%CI, 1.8-7.0) in the Cape metropolitan area. This 
may in part explain the diff rences in the epidemiology of asthma between 
males and females with respect to both asthma prevalence and severity. 42 
Some of these differences have also been ascribed to "immune dimorphism", 
a term describing the difference in immune responses and regulation between 
the two sexes.43 In this population, occupational factors such as gender-based 
job allocations in the seafood-processing industry may also result in women 
experiencing higher exposures to respiratory irritants and allergens and 
therefore being more at risk of developing asthma.44 Of interest too is the 











worker population (62%) which is considerably higher than the population 
norm of 34% as described by Ehrlich et al.5 
The reported prevalence of allergic ocular-nasal symptoms in this study is 
relatively high, whilst the prevalence of those on treatment is surprisingly low. 
The low numbers of respondents on treatment for asthma and ocular-nasal 
symptoms may reflect both under-diagnosis and under-treatment of these 
conditions which is a common finding in developing countries.45 It may also in 
part reflect difficulty with access to appropriate healthcare services for the 
treatment of these conditions. This is an important issue to address in health 
service provision for chronic respiratory disease since upper airway symptoms 
are an important risk factor for lower airway disease.54 
A medical history of treatment for chronic bronchitis and recurrent chest 
infections in childhood demonstrated a significant association with all asthma 
outcomes. The population attributable fraction of recurrent chest infections in 
childhood in relation to a diagnosis of current asthma was high (42.5%). This 
underscores the importance of pre-existing respiratory disease in the 
manifestation of asthma in this population as has been well illustrated in the 
life course approach to chronic diseases (Figure 4).46 It has certainly been 
recognized that respiratory viral infections may influence the course of asthma 
at different time points and animal data suggests that the link between 
respiratory viral infections and increased asthma is causally related, with viral 
infections acting on the immune and structural cells to enhance antigen 











consistent relationship between a childhood history of treatment for recurrent 
chest infections and COPD was also demonstrated in this study. This 
suggests that recurrent respiratory infections in childhood may markedly 
increase susceptibility to the development of COPD in adult life most likely 
through its negative impact on lung function. 
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Figure 4 depicting a schematic representation of biological and psychosocial exposures 
acting across the life course that may influence lung function and/or respiratory disease 
Source 8en-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: 












This study also demonstrated that a past history of pulmonary tuberculosis 
emerged as a strong and significant predictor for all COPO outcomes. This 
was similar to the findings of Ehrlich et al. 7 Similarly, in a recent community 
survey of Cape Town residents, Jithoo et al found that TB was strongly 
associated with symptoms of obstructive lung disease such as recent wheeze 
(OR, 2.1; 95% CI, 1.5 - 2.9), wheeze with breathlessness (OR, 1.9; 95%CI 
1.3 - 2.7) and dyspnoea grade 2 or higher (OR, 2.1; 95%CI, 1.5 - 2.9).48 In 
South Africa, airway obstruction has also been documented in 18.4% of gold 
miners who had previously been treated for TB.49 In this group of miners 
chronic lung function impairment was shown to increase incrementally with 
the number of episodes of tuberculosis reported. In the clinical context, Wilcox 
et al reported the presence of airflow obstruction in up to 68% of patients who 
had previously been treated for TB.50 While little is known about the 
pathophysiology underlying this association, residual damage to lung tissue 
following completion of TB has been demonstrated resulting in varying 
degrees of 'fibrosis, bronchovascular distortion, emphysema and 
bronchiectasis. 49 In this current study, the population attributable fraction for 
TB in relation to fixed airway obstruction was 20.1% suggesting that a focus 
on TB prevention and appropriate management may substantially reduce the 
morbidity associated with obstructive lung disease in this population. Given 
the high prevalence of TB in this population and the considerable impact of 
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One of the surprising findings in this study showed that whilst smoking was 
positively associated with CO PO outcomes, the association was not 
significant. This is in contrast to the national population-based studies that 
showed a significant if complex association between chronic bronchitis 
symptoms and heavy smoking (>15 cigarettes Iday) in men (OR, 2.5; 95%CI, 
1.2 - 5.3) and light smoking (1 - 14 cigarettes) in women (OR, 2.3; 95%CI, 
1.4 - 3.8).7 The population attributable fraction of chronic bronchitis related to 
smoking reported by Ehrlich et al was 25% in men and 11 % in women 
illustrating the public health impact of this important risk factor. The lack of an 
association in this current study is unexpected given the high prevalence of 
smoking in this population and the well-known aetiological role of smoking in 
COPD. Furthermore, detailed analysis showed that the association was not 
modified by either age or sex. However, the point estimates for the 
association between current smoking and fixed obstruction is similar to that 
found in other studies and the lack of significance at alpha=O.5 appears to be 
due mainly to the much smaller sample size imposing a lack of power in 
demonstrating underlying associations. 37 The use of the GOLD definition of 
airway obstruction may also have resulted in younger people with obstructive 
lung disease being classified as normal. 51 More recent ATS IERS guidelines 
have proposed a new definition of airway obstruction as a reduction of 
FEV1/FVC below the fifth percentile of the predicted value for an individual, to 
counter the problem of misclassification.52 
The importance of occupational factors in the epidemiology of obstructive lung 


















of the excess cases of obstructive lung disease in the general population.1 In 
this current study, the occupational factor that continued to have a strong and 
consistent relationship with all asthma outcomes was the presence of 
work-related tight chest or wheeze which showed a twofold increase in the 
risk of having NSBH (OR, 2.01; 95% CI, 1.19 -3.40). This is consistent with 
the results of the community survey by Van Schalkwyk et al that demonstrated 
a very strong association between NSBH and work-related wheeze or tight 
chest (OR, 6.00; 95%CI, 2.5 - 14.5).12 In this current study, workers who 
reported experiencing peak exposures to dusts, fumes and gases in the 
workplace were also found to be at far higher risk of having current asthma 
(OR, 3.7; 95% CI 1.72 - 7.93) or doctor-diagnosed asthma (OR, 2.56; 
95%CI, 1.31 - 5.02). Both these associations are probably mediated through 
the irritant effects on the respiratory system caused by exposure to 
bioaerosols, microorganisms and toxins present in the work environment 
associated with seafood processing.53 In the multivariate analysis work-
related ocular-nasal symptoms was also associated with asthma symptoms 
(OR, 3.13; 95% CI, 1.83 - 5.35) and chronic bronchitis symptoms (OR, 4.22; 
95%CI, 1.64 - 10.87). The association between ocular-nasal symptoms and 
the development of asthma symptoms is consistent with findings from studies 
performed in occupational settings.54,55 There is also increasing evidence for 
an interaction between upper and lower airways in the development and 
severity of asthma and rhinitis, which has led to the term united airways 
implying the two should be considered a common immunopathologic entity.56 
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In examining the relationship with COPO outcomes, occupational factors were 
highly predictive of chronic bronchitis symptoms but not for spirometry-based 
definitions of COPO. This may in part be related to the relatively young age of 
the population and the short duration (mean, 10 years) of occupational 
exposure that may not be long enough for lung function decline to become 
apparent.37 Consideration should also be given to the impact of selection bias 
manifesting as the 'healthy worker effect' as subjects who smoke heavily and 
who have symptoms of asthma or COPO may be less likely to seek 
employment or may have left the industry earlier leaving behind workers with 
generally better health status. Symptom-based diagnoses are also more 
vulnerable to information bias as it relies on participants' understanding and 
recall of relevant symptoms which may not always be accurate. 
In this study, atopy was associated with all asthma outcomes with the 
strongest association occurring with respect to current asthma (OR, 3.42; 
95%CI, 1.62 - 7.24). Allergic sensitization is known to be associated with a 
large proportion of adult asthma and ongoing allergen exposure may also 
predispose to an enhanced response to a second allergen.2.42 The strong 
association between atopy and asthma outcomes was driven mainly by 
sensitization to indoor allergens of which house dust mite was the 
predominant allergen causing sensitization. Sensitivity to anyone of the 
indoor allergens was also strongly associated with all asthma outcomes. 
Despite a low prevalence of Aspergillus sensitization (2%) in this population, 
sensitization to Aspergillus was strongly associated with asthma symptoms 












95%CI, 1.05 -14.54). A similar association with the presence of NSBH (OR, 
2.5; 95%CI, 1.00 - 6.00) has been observed in a much larger community-
based study by van Schalkwyk et al suggesting a consistent association with 
asthma outcomes. 12 
In this current study seafood intake was high ranging from 28% for abalone to 
99% for fish. These seafoods are known to be rich in omega-3 fatty acids. 
The n-6 polyunsaturated fatty acids dihomo-gamma linoleic acid, linolenic acid 
and arachidonic acid were associated with an increase in the risk of NSBH 
with arachidonic acid also predictive of doctor-diagnosed asthma. This 
supports results from a previous study and is consistent with the pro-
inflammatory role of n-6 PUFAs hypothesized to playa role in the 
pathogenesis of asthma.31 •32 Similarly, the negative association of n-3 PUFAs 
with NSBH in particular suggests that diets rich in EPA, DPA and 24:0 may 
confer some protection against the development of asthma. This effect is 
biologically plausible as n-3 PUFAs shunt eicosanoid production away from 
the arachidonic pathway resulting in a decreased production of 
bronchoconstrictive leukotrienes. 57 The lack of a relationship between atopy 
and serum fatty acid levels is however contrary to studies in children that have 
demonstrated a role for n-6 PUFAs in atopy and have implicated dietary 
change as an important factor in the growing prevalence of asthma and 
allergic disease.31 The findings of this current study and that by Wood at al 
suggest that the relationship between atopy and serum fatty acids is of less 
importance in adults with asthma whilst the consistent relationship with NSBH 

















The use of spirometry-based diagnoses is strength of this study and 
represents an attempt to overcome some of the biases related to the use of 
self-reported symptoms in defining outcomes. However the consistency 
between spirometry based diagnoses and symptom- based diagnoses 
suggests that symptom-based diagnoses were quite robust and sensitive in 
this population. A limitation is the cross cross-sectional design which makes it 
impossible to determine temporal sequence required to infer causality. 
Although consideration has been given to the healthy worker effect it is 
difficult to ascertain how large an impact this would have had on the 
prevalence of obstructive lung disease in this population. The agreement 
between our estimates and that found in a national survey suggests that such 
an impact was not marked. 
In conclusion, it is recommended that future research focus on the further 
investigation of the pathophysiology underlying the strong association 
between TB and obstructive lung disease. Public health policies geared at the 
successful preventio  and management of the TB epidemic may well lessen 
the burden posed by obstructive lung disease. There is also a need for 
prospective studies examining occupational exposures to characterize the 
nature and directionality of associations between occupational exposures and 
obstructive lung disease. Given the important contribution of occupational 
exposure to the burden of obstructive lung disease in general, greater effort 
should be expended to decrease environmental exposure to respiratory 
irritants and allergens in the workplace. Furthermore, the potential protective 
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relationship between dietary polyunsaturated fats and asthma is biologically 
plausible and presents an opportunity for further research as dietary 
manipulation may well present a cost-effective way to lessen the burden of 
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UCT OCCUPATIONAL SEAFOOD ALLERGY STUDY IN  
SOUTH AFRICA - 2001  
ENGLISH QUESTIONNAIRE  
Cardl 
RECORD NO: ____ 
A. IDENTIFICATION DATA 
1. Surname 
2. First name/ s 
3. Address 
4. Work number 	
5. Date of birth 	 Day_ Month_ Year 19_ DDDDDDlO-l5 
6. Gender Male (1) 
Female (2) 
7. 	Home language English _ (I) 
Afrikaans _ (2) 
Xhosa _(3) 
Other _ (4) 
8. Interviewer's initials 
9. Date of interview 	 Day _ Month _ Year 20_ DDDDDD19-24 
10. Factory___________ 













I am going to ask you some questions about your health. At first these will be mostly about 
your breathing. Wherever possible, I would like you to answer 'YES' or 'NO'. 
I Circle (0) appropriate responses. 
Wheeze and tightness in the chest 
1. Have you had wheezing or whistling in your chest at any time in the last 12 months? 
YES (1) NO (2) 
If YES, go on to Question 1.1 
If NO, skip to Question 2 
1.1 	Have you been short of breath when the wheezing noise was present?  
YES (1) NO (2)  
1.2 Have you had this wheezing or whistling when you did not have a cold or flu? 
YES (1) NO (2) 
2. 	Have you been woken up with a feeling of tightness in your chest at any time in the last 12 
months? 
YES (1) 	 NO (2) 
Shortness of breath 
3. 	Have you had an attack of shortness of breath that came on during the daytime when you 
were at rest at any time in the last 12 months? 
YES (1) 	 NO (2) 
4. Have you had an attack of shortness of breath that came on following running or exercise 
at any time in the last 12 months? 











5. Have you been woken by an attack of shortness of breath at any time in the last 12 
months? 
YES (1) NO 	(2) 
Cough and phlegm from the chest 
6. Have you been woken by an attack of coughing at any time in the last 12 months? 
YES (1) NO (2) 034 
7. Do you usually cough first thing in the morning? 
YES (1) NO (2) 
8. Do you usually cough during the rest of the day, or at night? 
YES (1) NO (2) 
If YES, go on to Question 8.1 
If NO, skiQ to Question 9 
8.1 Do you cough like this on most days/nights for as much as three or more months in 
each of the last two years? 
YES (1) NO 	(2) 
9. 	Do you usually bring up any phlegm from your chest first thing in the morning? 
YES (1) NO (2) 
10. Do you usually bring up any phlegm from your chest during the day, or at night? 
YES (1) NO (2) 
If YES, go on to Question 10. 1 
If NO, skip to Question 11 
10.1 Do you bring up phlegm like this on most days/nights for as much as three or more 
months in each of the last two years? 












11. Do you ever have trouble with your breathing? 
YES (1) NO (2) 
If YES, go on to Question 11.1 
If NO, skip to_Question 12 
11.1 Do you have this trouble: 
Give all options at once 
Insert a cross (X) next to one answer only 
a) continuously so that your breathing is never quite right?  
b) repeatedly, but it goes away completely between the times  
when it troubles you?  
c) only rarely?  
12. Are you disabled from walking by a condition other than heart or lung disease? 
YES (1) NO (2) 
If YES, state the condition 
and go on to Question 13 
If NO, go to Question 12.1 
12.1 Are you troubled by shortness of breath when hurrying on level ground or 
walking up a slight hill? 
YES (1) NO (2) 
If YES, go on to Question 12.1.1 
If NO, skip to Question 13 
12.1.1 	Do you get short of breath walking with other people of your own age on level 
ground? 
YES (1) NO (2) 
If YES, go on to Question 12.1.1.1 











12.1.1. 1 Do you have to stop for breath when walking at your own pace on level 
ground? 
YES (1) NO (2) 
Asthma 
13. Have you ever had asthma? 
YES (1) NO (2) 
If YES, go on to Question 13.1 
If NO, skip to Question 13.8 
13.1 If yes, was this confirmed by a doctor? 
YES (1) NO (2) 
13.2 How old were you when you were told you have asthma? 
Give all options at once 
Insert a cross (X) next to one answer only 
a) Only before you were 17 years old 
b) Only at the age of 17 years or older 
c) Both 
The following references to "attack" of asthma refers to episodes of wheezing, 
shortness of breath, chest tightness or cough attributed to asthma 
13.3.1 How old were you when you had your first attack of asthma? 
_ _ _ years old 0050-51 
13.3.2 How old were you when you had your most recent attack of asthma? 
___ years old 0 052-53 
13.4.1-6 Which months of the year do you usually have attacks of asthma? 
13.4.1 JanuaryjFebruary YES (1) NO (2) 054 











13.4.3 May/June YES (1) NO (2) 0 56 
13.4.4 July / August YES (1 ) NO (2) 0 57 
13.4.5 September/October YES (1) NO (2) 0 58 
13.4.6 November/December YES (1) NO (2) 0 59 
13.5 Have you had an attack of asthma in the last 12 months? 
YES (1) NO (2) 
IfYES, _go on to Question 13.5.1 
If NO, to Question 13.6 
13.5.1 How often have you had an attack of asthma in the last 12 
months? 
Give all options at once 
Insert a crossJX) next to one answer only 
a) Every day  
b) More than 2 times a week  
c) More than 1 time per month  
d) 3 to 12 times in the whole year  
e) 1 to 2 times in the whole year  
13.6 Are your chest symptoms caused by, or made worse by any of the following: 
Answer all questions 
13.6.1 Contact with animals/pets YES (1 ) NO (2) 062 
13.6.2 Grass or flowers YES (1) NO (2) 0 63 
13.6.3 Heavy exercise YES (1) NO (2) 0 64 
13.6.4 Breathing cold air YES (1) NO (2) 0 65 











13.6.6 Tobacco smoke YES (1) NO (2) 
13.6.7 Change in the weather YES (1) NO (2) 
13.7 Do your chest symptoms seem better or worse when you are 
away from work (for example, on weekends, off-shift and vacations)? 
Give all options at once  
Insert a cross (X) next to one answer only  
a) Stay the same  
b) Get better  
c) Get worse  
13.8 Does being at work ever make your chest tight or wheezy? 
YES (1) NO (2) 
on to Question 13.8.1 
If NO, skip to Question 13.9 
13.8.1 When did you first notice having problems with chest tightness or wheeze at 
work? 
Date: Month Year 0 00071-74 
13.8.2 Is there anything that you work with that causes you to have these chest 
symptoms? 
YES (1) NO (2) 
If YES, go on to Question 13.8.3 
If NO, skip to Question 13.9 











13.9 Have you ever had to change or leave your work area, either temporarily or permanently, 
in this factory or any other factory because of any chest symptoms? 
Card 2 
YES (1) NO (2) 
If YES, go on to Question 13.9.1 
If NO, skip to Question 13.10 
13.9.1 What type of job were you doing when this happened? 
13.9.2 Was this ajob in this factory? 
YES (1) NO (2) 
If YES, go on to Question 13.9.2.1 
If NO, skip to Question 13.10 
13.9.2.1 What department did you move to? 
005.6 
13.9.2.2 What job did you do there? 
13.9.2.3 Did your symptoms improve when you changed jobs? 
YES (1) NO (2) 
13.10 Have you ever worked in ajob or jobs that exposed you to vapours, 
gas, dust or fumes? 
YES (1) NO (2) 
If YES, go on to Question 13.10.1. List the jobs beginning with the most recent 











13.10.1 What was or is this job? ____ _______ _ 0011-12 
(if current job write 'current job') 
13.10.2 Before that? ___________ _ _ ___ 0013-14 
13.10.3 Before that? _ ___ _____________ 0015-16 
13.11 	Has there ever been an instance when you inhaled a large amount of vapours, gas, dust 
or fumes in any of these jobs that resulted in you developing a tight chest, wheeze or 
cough? 
YES 	 (1) NO (2) 
If YES, go on to Question 13.11.1. 
If NO, skip to Question 13.12 
13.11.1 What was or is this job? __________ 0018-19 
(if current job write 'current job') 
13.12 Are you using any medicines, including inhalers/pumps, nebulizers, syrups or tablets, 
for asthma or breathing problems? 
YES 	 (1) NO (2) 
If YES, go on to Question 13.12.1, showing examples of each 
If NO, skip to question 13.13 
13.12.1 Which medicines? _____ _________ _ 
13.12.2 Do you take these medicines every day even when you do not have any trouble 
breathing? 











13.13 Have you ever been treated for any of the following: 
Answer all questions 
13.13.1 Repeated chest infections as a child YES (1 ) NO (2) UNK (3) 025 
13.13.2 Tuberculosis (TB) 	 YES (1) NO (2) UNK (3) 026 
13.13.3 Chronic bronchitis 	 YES (1) NO (2) UNK (3) 027 
Nose and ey:e sy:m2toms 
14. Have you ever had any nose or eye problems or allergies such as hay fever? 
YES (1) NO (2) 
14.1 How old were you when you first noticed these 	symptoms? 
years old 	 0029-30 
If YES, go on to Question 14.2 Answer all questions 
If NO, skip to Question 14.4 
14.2 During the past 12 months have you had two or more episodes of: 
14.2.1 	sneezy, itchy or runny nose when you did not have a cold or flu? 
YES (1) NO (2) 
14.2.2 red, itchy or watery eyes 	 YES (1) NO (2) 
14.2.3 Do you usually have the nose or eye YES (1) NO (2) 
symptoms at any particular time of the year? 
14.2.3.1 If YES, which is the worst season? 
Give all options at once 





If YES to any of the above, go on to Question 14.3 











14.3 Do your nose or eye symptoms seem better or worse when you are 
away from work (for example, on weekends, off-shift and vacations)? 
Give all options at once 
Insert a cross (X) next to one answer only 
a) Stay the same  
b) Get better  
c) Get worse  
14.4 Does being at work ever cause you to have sneezy/itchy/runny nose or red/itchy/watery 
eyes? 
YES (1) NO (2) 
If YES to anyone of the above, go on to Question 14.4.1 
If NO, skip to Question 14.6 
14.4.1 Since when have you been having these symptoms at work? 
Date: Month Year 000037-40 
14.4.2 Is there anything that you work with that causes you to have these 
symptoms? 
YES (1) NO (2) 
If YES, go on to Question 14.4.3 
If NO, skip to Question 14.5 
14.4.3 What do you think is causing these symptoms? 
14.5 Are you using any medicines, including nose sprays, drops, tablets or injections, for your 
nose or eye symptoms at present? 
YES (1) NO (2) 
If YES, go on to Question 14.5.1 











14.5.1 Which medicines? ________________ 
14.6 Did you have hay fever (itchy or watery eyes/nose) as a child? 
YES (1) NO (2) 
Skin symptoms 
15. 	Have you ever had any kind of skin problem either at home or at work? 
YES (1) NO (2) 
If YES, go on to Question 15.1 
If NO, skip to Question 15.4.4 
15.1 How old were you when you first noticed this skin problem? 
____ years old 	 0048-49 
15.2 During the past 12 months have you had any skin problems that occurred 2 or more 
times? 
YES (1) NO (2) 050 
If Yes, which of the following problems did you have? 
Go through each option in the table below and circle the appropriate response. 
Forearms Face I Legs Whole Body 
Hands Neck Knees 
15.2.1 
itchy or scratchy skin Yes/No 051 Yes/No 052 Yes/No 053 Yes/No 054 
15.2.2 
hives ("bommels") Yes/No 055 Yes/No 056 Yes/No 057 Yes/No 058 
15.2.3 



















redness of the skin Yes/No 063 Yes/No 064 Yes/No 065 Yes/No 066 
15.2.5 
blisters or weeping skin Yes/No 067 Yes/No 068 Yes/No 069 Yes/No 070 
15.2.6 
burning skin Yes/No 07l Yes/No 072 Yes/No 073 Yes/No 074 
15.2.7 
started within an hour of 
contact with a substance 
or food item 
Yes/No 075 Yes/No 076 Yes/No 077 Yes/No 078 
15.2.8 
Other? Specify: Yes/No 01 
Card 3 Yes/No 02 Yes/No 03 Yes/No 04 
If YES, to any of the above go on to Question 15.3 
If NO, skip to Question 15.4 
15.3 Do your skin problems seem better or worse when you are away from work (for example, 
on weekends, off-shift and vacations)? 
Insert a cross X next to one answer onl 
a) Stay the same  
b) Get better  
c) Get worse  
15.4 Does being at work ever cause you to have skin problems? 
YES (1) NO (2) 
If YES, go on to Question 15.4.1 
If NO, skip to Question 15.4.4 
15.4.1 	Since when have you been having these skin problems at work? 











15.4.2 Is there anything that you work with that makes these problems 
(1) NO (2) 11 
1 What do you think is causing skin problems? 
12 
or hands while working 
with the seafood? 
15.4.4 Have you ever cut or injured your 
YES (1) NO (2) 13 
1 5 Do wear gloves while working? 
(1) NO (2) 14 
15.4.5.1 How do you wear gloves while working? 15 
a) most of time  
b) less half the  
c) occasionally  















15.4.5.3 Which type of glove are you using most of the time while working? 
Ask workers to choose from the selection and place the number in the space provided below 
Glove used: ___ _ _ 
15.4.5.4? Do you use any other gloves while working? YES (1) NO (2) 
If yes, which ones? (choose from the same selection) 
a)  
b)  
15.4.5.5 Are your gloves washed at the end of each shift? 
YES (1) NO (2) 
15.4.5.6 Are your gloves washed with a disinfectant on a regular basis (almost every 
day)? 
YES (1) NO (2) 
15.4.5.7 Are your hands still wet even though you use gloves while working? 
YES (1) NO (2) 
15.5 How many times do you wash your hands in the course of a day? 
Give all options at once 





6 or more 
15.6 Are you using any medicines, including any creams or ointments, for your skin problems 
at present? 











15.6.1 Which medicines? ___________ _ _ 
15.7 Did you have eczema as a child? YES (1) NO (2) 
Other allergic conditions 
16. Are you allergic to insect stings or bites? YES (1) NO (2) 
If YES, go on to Question 16.1 
If NO, skip to Question 17 
16.1.1-3 What kind of reactions do you have? 
16.1.1 Breathing difficulty, feeling faint, fever? YES (1) NO (2) 
16.1.2 Redness, itching or swelling at the sting site YES (1) NO (2) 
16.1.3 Other: ___ ________ 
17. Have you ever had any difficulty with your breathing after taking medications or injections 
that you did not have before? 
YES (1) NO (2) 
If YES, go on to Question 17.1 
If NO, skig to 18.1 
17.1 Which medicines? ____ _________ _ 
18.1-6 When you are near animals (such as cats, dogs or horses), near feathers (including 
pillows, quilts or duvets), near grass and flowers, or in a dusty part of the house, do you ever 
18.1 Start to cough? YES (1) NO (2) 0 35 
18.2 Start to wheeze? YES (1) NO (2) 0 36 
18.3 Get a tight chest? YES (1) NO (2) 0 37 











18.5 Get a runny/stuffy nose or sneeze? YES (1) NO (2) 0 39  
18.6 Get itchy or watery eyes? YES (1) NO (2) 0 40  
18.7 Get itchy skin/rash? YES (1) NO (2) 0 41  
19. Have you ever had an illness or trouble caused by eating a particular type of food/fruit or 
drinking a particular juice / drink? 
YES (1) NO (2) 
If YES, go on to Question 19.1 
If NO, skip to 20 
19.1 What type of food/drink was this?  
19.1.1-6 Did this illness or trouble include:  
19 .1.1 Itchy skin or rash YES (1) NO (2) 0 43  
19.1.2 Diarhoea or vomiting YES (1) NO (2) 0 44  
19.1.3 Runny or stuffy nose YES (1) NO (2) 0 45  
19.1.4 Severe headaches YES (1) NO (2) 0 46  
19.1.5 Breathlessness/tight chest/wheeze YES (1) NO (2) 0 47  
19 .1.6 Other:  0 48 
19.2 Was the food canned or preserved? YES (1) NO (2) 0 49  
19.3 Do you experience these problems YES (1) NO (2) 0 50  











20. Are you allergic to seafood such as fish, crabs, prawns, lobster, mussels? 
YES (1) NO (2) 051  
If YES, go on to Question 20.1  
If NO, skip to next Section C on FAMILY HISTORY  
20.1.1-9 What kind of reactions do you have?  
20.1.1 hives/itchy wheals YES (1) NO (2) 052  
20.1.2 eczema YES (1) NO (2) 053  
20.1.3 nausea/vomiting/ stomach pain/ YES (1) NO (2) 054  
diarhoea  
20.1.4 wheezing/tight chest/ YES (1) NO (2) 055  
difficulty breathing  
20.1.5 itching of tongue/lips YES (1) NO (2) 056  
20.1.6 swelling/itching of throat YES (1) NO (2) 057  
20.1.7 dizziness/ collapse YES (1) NO (2) 058  
20.1.8 fever/general weakness/joint pains YES (1) NO (2) 0 59  
20.1.9 Other:  060 
20.2 When do you experience these reactions?  
20.2 .1 After eating seafood YES (1) NO (2) 061  
20.2.2 After touching seafood YES (1) NO (2) 062  











20.3 Which seafood do you suspect are causing the symptoms? 
20.3.1 Hake YES (1) NO (2) 0 64 
20.3.2 Snoek YES (1) NO (2) 065 
20.3.3 Mackerel YES (1 ) NO (2) 0 66 
20.3.4 Anchovy YES (1) NO (2) 067 
20.3.5 Sardines (pilchard) YES (1) NO (2) 068 
20.3.6 Red eye YES (1) NO (2) 069 
20.3.7 Mussels YES (1) NO (2) 070 
20.3.8 Perlemoen YES (1 ) NO (2) 0 71 
20.3.9 Crayfish YES (1) NO (2) 0 72 
20.3.10 Prawns YES (1) NO (2) 073 
20.3.11 Haarders (bokkom) YES (1) NO (2) 0 74 
20.3.12 Other 0 75 
20.4 When did you first experience these reactions? 
20.4.1 Before working in the seafood YES (1) NO (2) 076 
industry 
20.4.2 After beginning work in the YES (1) NO (2) 0 77 
seafood industry 
20.5 Have you ever experienced any of these reactions during or after working or 
handling seafood? 
See list of reactions under question 20.1 if a reminder is needed 
Card 4 











If YES, _go on to Question 20.5.1 
If NO, slqp to next Section C on FAMILY HISTORY 
20.5.1 What were you busy doing? _ _ ___________ 
20.5.2 Where were you handling/working with the seafood? 
20.5.2.1 at work YES (1) NO (2) 
20.5.2.2 at home YES (1) NO (2) 
20.5.2.3 recreational activities (fishing, diving) 
YES (1) NO (2) 
20.5.2.4 Other? Specify ____ _ _ _ _ ___ 
20.5.3 What reaction/ s did you experience? 
20.5.4 What seafood/s were you working with? 
20.5.5 When did the reaction occur?: 
Give all options at once 
Insert a cross (X) next to one answer only 
a) within 1hour 
b) within 1 to 3 days 











c. FAMILY HISTORY 
1. Do/did any members of your family (blood relatives) ever have any kind of allergies? 
Do not include relatives by marriage 
If family history is completely unknown (subject is adopted, etc.), mark UNK and 
do not complete table. Move to next section 
YES (1) NO (2) UNK (3)  
If YES, complete table below. Insert a cross (X) in the appropriate block for each 
option. 
Type of Allergy NO 
ONE 




Parent Brother Child 
/sister 
1. 1 Hay fever 
1 2 3 4 5 11 
1.2 Eczema 
1 2 3 4 5 12 
1.3 Asthma 
1 2 3 4 5 13 
1.4 Seafood Allergy 
1 2 3 4 5 14 
1.5 Other allergy 












D. SMOKING HISTORY 
1. Have you ever smoked tobacco (cigarettes or pipe) for as long as a year? 
'YES' means at least 20 packs of cigarettes or 360 grams of tobacco in a lifetime 
or at least one cigarette Qer dayfor one year 
YES (1) NO (2) 
If YES, go on to Question 1.1 
If NO, skiQ to Question 2 
1.1 How old were you when you started smoking? 
____ years old 0017-18 
1.2 Do you now smoke? 
'YES' means smoking tobacco in the last month or mor  
YES (1) NO (2)  
If YES, go on toQuestion 1.2.1 
If NO, skip to Question 1.3.1  
1.2.1-2. How much do you now smoke on average?  
1.2.1 Number of cigarettes per day___ ___ 0020-21 
1.2.2 Pipe tobacco in gramsjweek.______ 0 0022-24 
show different packets of tobacco for pipe smokers 
1.3. Have you stopped smoking completely? 
YES (1) NO (2) 
If YES, go on to Question 1.3.1 











1.3.1. How old were you when you stopped smoking completely? 
_ ___ years old 
1.3.1.1 	How many years in total did you smoke cigarettes? 
(Do not include the years you stopped before you 
started again) 
_ ___ years 
1.3.2.1-2 On average of the entire time you smoked,  
how much did you smoke?  
1.3.2.1 	Number of cigarettes per day _____ 
1.3.2.2 	Pipe tobacco in grams/week 
1.4 Do you or did you inhale the smoke? 




0 0 0 32-34 
2. Have you been regularly exposed to tobacco smoke from other people smoking cigarettes or 
pipe in the last 12 months? 
'Regularly' means on most days or nights 











E. DIETARY HISTORY - SEAFOOD INTAKE 
This section is on eating seafood. 
1. How often have you eaten the following seafood in the last 12 months? 
Go through each seafood option and insert a cross (X) in the block for each 
op_tion 
Type of seafood Never Less than once a 
month 
Once or more than 
once a month 
1. Fish: fried, cooked canned or 
dried 
(eg. Haarders (bokkom), snoek, 
tuna, mackerel etc.) 
1 2 3 37 
2. Crayfish or prawns 1 2 3 38 
3 . Calamari 1 2 3 39 
4. Perlemoen 1 2 3 40 
5 . Oyster jMussels 1 2 3 41 
6. Other: 1 2 3 42 
Ir 
2. Have you changed your diet or avoided certain seafood because they do not agree withyou 
when you eat them? 
YES (1) NO (2) 043 
If YES, go on to Question 2.1 
If NO, skiQ to next Section F on WORK HISTORY 













F. WORK HISTORY IN SEAFOOD PROCESSING 
I am going to ask you about your present work 
Use company record of work history, if available, to prompt worker's memory 
1. 	How long have you been working at this factory? 
_ _ _ _ years 0048-49 
_ ___ months 0 050-51 
Present job 
2. 	How long have you been working in your current job? 
_ _ _ _ years 0052-53 
_ ___ months 0054-55 
3. In which department are you currently working? 	 0056-57 
3.1 What is your job in this department? 0 0 58-59 
Job Title 
get a short description of the job 
3.2 Do you ever do other jobs during your shift on a regular basis (almost every day)? 
YES (1) NO (2) 060 











3.3 Are you currently a seasonal, permanent or casual worker? 
Give all options at once 
Insert a cross (X) next to one answer only 
a) Seasonal  
b) Permanent  
c) Casual  
3.4 How much dust or mist/ spray/ steam would you say that this job produces: 064 
Give all options at once 
Insert a cross (X) next to one answer only 
a) None 
b) A little 
c) An average amount 
d) A lot 
3.4.1 How far do you work from the source of the dust or mist/spray/steam? 0 65 
Mention all options at once 
Insert a cross (X) next to one answer only 
a) Right next to the source  
b) About 1-2 metres away  
c) More than 2 metres away  
d) Does not apply  
3.5 Do you use any personal protective equipment on a regular basis (almost every day) while 
doing your job? 
YES (1) NO (2) 
If NO, skip to Question 4 
If YES, continue with Question 3.5.1 
3.5.1 Which of the following personal protective equipment do you use on a regular basis 
(almost every day)? 
3.5.1.1 Goggles: YES (1) NO (2) 











3.5.1.3 Mask: YES (1 ) NO (2) 069 
0703.5.1.4 Aprons: YES (1 ) NO (2) 
0713.5.1.5 Other: 
If NO to all of the previous questions, skip to Question 4 
If YES to anyone of the above questions, continue with Question 3.5.2 
3.5.2 How long have you been wearing the personal protective equipment on a regular 
basis (almost every day) while working? 
3.5.2.1 Goggles: ____ yrs 0072-73 
3.5.2.2 Gloves: _ _ __ yrs 0074-75 
3.5.2.3 Mask: ____ yrs 0076-77 
3.5.2.4 Other: ___ _ yrs 0078-79 
Previous jobs in present factory 
4. Before doing this job at this factory, did you do a different job here? 
Card 5 
YES (1) NO (2) 
If NO, skip to question 5 
If YES, continue with question 4.1 
4.1 What other jobs did you do here? 
Start with the first job and work forward, getting a one-line description of each job. If casual 
worker, denote each period of employment as a separate job. For continuous years of seasonal 












4.1.1 Department _ _ _ _____ _____ _ _ _____ 
4.1.2 Job Title 
get a short description of the job 
4.1.3 Seasonal/permanent/casual: ______ 
4.1.4. How long did you work in this job? ____ years 
_ _ __ months 009-10 
4.1.5 How much dust or mist/spray/steam would you say that this job produced: 
Give all options at once 
Insert a cross (X) next to one answer only 
a) None  
b) A little  
c) An average amount  
d) A lot  
4.1.6 Which of the following personal protective equipment did you use on a 
regular (almost every day) basis while working? 
4.1.6.1 Goggles: YES (1) NO (2) 012 
4.1.6.2 Gloves: YES (1) NO (2) 013 












4.2.1 DeparlInent ____________________________________________ 0015-16 
4.2.2 Job Title 0017-18 
get a short description of the job 
4.2.3 Seasonal/permanent/casual: ______ 
_ _____ years4.2.4. How long did you work in this job? 0020-21 
_ _____ months 0022-23 
4.2.5 How much dust or mist/ spray/ steam would you say that this job produced: 
Give all options at once 
Insert a cross (X) next to one answer only 
a) None 
b) A little 
c) An average amount 
d) A lot 
4.2.6 Which of the following personal protective equipment did you use on a regular (almost 
every day) basis while working? 
4.2.6 .1 Goggles: YES (1) NO (2) 025 
4.2 .6.2 Gloves: YES (1) NO (2) 026 
4.2.6.3 Mask: YES (1 ) NO (2) 027 
Job 3 
4.3.1 DeparlInent ________________ __________________ __ 0028.29 














I get a short descri2tion of the job I 
0 324.3.3 Seasonal/permanent/casual: 
4.3.4. How long did you work in this job? years 0 033-34 
months 0035-36 
4.3.5 How much dust or mist/spray/steam would you say that this job produced: 0 37 
Give all options at once 
Insert a cross{X) next to one answer only 
a) None  
b) A little  
c) An average amount 
- -
d) A lot  
4.3.6 Which of the following personal protective equipment did you use on a regular (almost 
every day) basis while working? 
4.3.6.1 Goggles: YES (1.) NO (2) 
4.3.6.2 Gloves: YES (1) NO (2) 
4.3.6.3 Mask: YES (1) NO (2) 
Job4 
4.4.1 Department 0 0 41-42 
4.4.2 Job Title 0 043-44 
get a short descri2tion of the job 












4.4.4. How long did you work in this job? ____ years 0 046-47  
_ ___ months 0 0 48-49  
4.4.5 How much dust or mist/spray/steam would you say that this job produced: 0 50 
Give all options at once  
Insert a cross (X) next to one answer only  
a) None  
b) A little  
c) An average amount  
d) A lot  
4.4.6 Which of the following personal protective equipment did you use on a regular (almost 
every day) basis while working? 
4.4.6.1 Goggles: YES (1) NO (2) 0 51 
4.4.6.2 Gloves: YES (1 ) NO (2) 0 52 
4.4.6.3 Mask: YES (1) NO (2) 0 53 
Reminder: Please do a general check to determine if the total number of years in each job 'I 
adds up to the total number of years in this factory. Refer to company records if available. 
Previous work in other seafood factories 
5. Have you worked in any other seafood processing factories in the past two years? 
YES (1) NO (2) 
If NO, ski to uestion 6 
,If YES, continue with uestion 5.1 











5.2 What is the total amount of time you have worked in seafood processing factories ever 
since you started working? 
Years_ __ Months _ _ _ 000056-59 
Previous work experience 
6. 	Name all the previous factories that you have worked in, when not working in this factory 
or before corrring to work in this factory: 
Start with the most recent job and work backwards (including all other seafood processing 
factories and 'obs done durin the off-season 

















THANK YOU FOR ANSWERING THE QUESTIONNAIRE  
100 
